MLICM
NUS icon

Metropolitan Life Insurance Company (MetLife)’s Nu Skin NUS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,718
Closed -$37.6K – 1415
2024
Q1 		$37.6K Sell
2,718
-156
-5% -$2.44K ﹤0.01% 1549
2023
Q4 		$55.8K Hold
2,874
– – ﹤0.01% 1389
2023
Q3 		$61K Buy
2,874
+147
+5% +$3.82K ﹤0.01% 1290
2023
Q2 		$90.5K Hold
2,727
– – ﹤0.01% 1072
2023
Q1 		$107K Sell
2,727
-391
-13% -$16.3K 0.01% 964
2022
Q4 		$131K Hold
3,118
– – 0.01% 920
2022
Q3 		$104K Hold
3,118
– – ﹤0.01% 995
2022
Q2 		$135K Hold
3,118
– – 0.01% 896
2022
Q1 		$149K Sell
3,118
-17,386
-85% -$862K 0.01% 964
2021
Q4 		$1.04M Sell
20,504
-236
-1% -$10.5K 0.01% 931
2021
Q3 		$839K Sell
20,740
-1,386
-6% -$70.1K 0.01% 1096
2021
Q2 		$1.25M Buy
22,126
+12,520
+130% +$713K 0.02% 844
2021
Q1 		$508K Buy
9,606
+467
+5% +$25.4K 0.01% 1401
2020
Q4 		$499K Sell
9,139
-319
-3% -$16.8K 0.01% 1350
2020
Q3 		$474K Sell
9,458
-591
-6% -$28K 0.01% 1253
2020
Q2 		$384K Sell
10,049
-4,727
-32% -$152K 0.01% 1399
2020
Q1 		$323K Sell
14,776
-803
-5% -$24.2K 0.01% 1318
2019
Q4 		$638K Buy
15,579
+95
+0.6% +$3.88K 0.01% 1181
2019
Q3 		$659K Sell
15,484
-1,203
-7% -$50.5K 0.01% 1115
2019
Q2 		$823K Buy
16,687
+7
+0% +$356 0.01% 1010
2019
Q1 		$798K Sell
16,680
-94
-0.6% -$5.7K 0.01% 1012
2018
Q4 		$1.03M Buy
16,774
+46
+0.3% +$3.1K 0.02% 794
2018
Q3 		$1.38M Sell
16,728
-170
-1% -$13.5K 0.02% 747
2018
Q2 		$1.32M Buy
16,898
+1,890
+13% +$146K 0.02% 780
2018
Q1 		$1.11M Buy
15,008
+131
+0.9% +$9.3K 0.02% 856
2017
Q4 		$1.01M Sell
14,877
-32,630
-69% -$2.11M 0.01% 879
2017
Q3 		$2.92M Buy
47,507
+87
+0.2% +$5.34K 0.02% 821
2017
Q2 		$2.98M Buy
47,420
+575
+1% +$32.8K 0.02% 824
2017
Q1 		$2.6M Buy
46,845
+44,637
+2,022% +$2.3M 0.02% 866
2016
Q4 		$105K Sell
2,208
-75
-3% -$4.2K ﹤0.01% 2532
2016
Q3 		$148K Sell
2,283
-66
-3% -$3.71K ﹤0.01% 2493
2016
Q2 		$109K Buy
2,349
+77
+3% +$3.1K ﹤0.01% 2588
2016
Q1 		$87K Hold
2,272
– – ﹤0.01% 2425
2015
Q4 		$86K Buy
2,272
+24
+1% +$884 ﹤0.01% 2511
2015
Q3 		$93K Hold
2,248
– – ﹤0.01% 2589
2015
Q2 		$106K Sell
2,248
-1,906
-46% -$103K ﹤0.01% 2601
2015
Q1 		$250K Hold
4,154
– – ﹤0.01% 1939
2014
Q4 		$182K Buy
4,154
+110
+3% +$4.86K ﹤0.01% 2473
2014
Q3 		$182K Sell
4,044
-30
-0.7% -$1.6K ﹤0.01% 2455
2014
Q2 		$301K Buy
4,074
+56
+1% +$4.41K ﹤0.01% 2203
2014
Q1 		$333K Hold
4,018
– – ﹤0.01% 2077
2013
Q4 		$555K Hold
4,018
– – ﹤0.01% 1741
2013
Q3 		$385K Sell
4,018
-54
-1% -$4.58K ﹤0.01% 1940
2013
Q2 		$249K Buy
+4,072
New +$226K ﹤0.01% 2192

Other funds holding NUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NUS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nu Skin (NUS) in Q2 2024, closing a stake of 2,718 shares — an estimated $37.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NUS in Q2 2013 and held it in 44 quarters. The position peaked at $2.98M in Q2 2017. 202 funds tracked by Wall St. Rank hold NUS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nu Skin position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,718 Nu Skin shares in Q2 2024, an estimated $37.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nu Skin in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nu Skin position peaked at $2.98M in Q2 2017.
  • 202 funds tracked by Wall St. Rank held Nu Skin as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.